— Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van Safety assessment — Strong performance across key categories, including Occupant Protection, Safety Assist/Crash Avoidance and Post-Crash Safety — Standard ADAS technologies – includingAEB, Lane Support System and Speed Assistance System – deliver high performance in demanding real-world test scenarios […]

First Horizon Bank (NYSE:FHN) announced today that Todd Warrick, Executive Vice President and Corporate and Commercial Market Leader, has been promoted to Triangle Market President for the Mid-Atlantic region. He will continue to report to Laura Bunn, Mid-Atlantic Regional President, and will remain responsible for leading First Horizon's Mid-Atlantic corporate and commercial banking, associate engagement

(NASDAQ:BIIB), TOKYO and CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that anti-AB protofibril* antibody “LEQEMBI(R)” (brand name in China: “ä¹æ„ä¿(R)“, generic name: lecanemab), has been included in the “Commercial

“LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List GlobeNewswire December 08, 2025 TOKYO and CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced

Calgary, Alberta–(Newsfile Corp. – December 8, 2025) – Builders Capital Mortgage Corp. (TSXV: BCF) (“Builders Capital” or “the Company“) had previously announced its intention to proceed with a participating bond offering (the “Bonds“) to raise gross proceeds of up to $50 million closing in one or more tranches (the “Offering“), the details of which are

Prominently featured in The Inner Circle,Ilene Fennoy, MD, MPH is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for her contributions to Pediatric Endocrinology and Child Health Advocacy. Dr. Ilene Fennoy has played a vital role in advancing pediatric endocrinology through clinical leadership, groundbreaking research, and a deep commitment to medical education. Since

Prominently featured in The Inner Circle, James W. Edlund, MD is recognized as a Pinnacle Lifetime Member for his contributions as a Distinguished Surgeon and Medical Director Advancing Wound Care Excellence. Dr. James W.Edlund, a respected leader in medicine, has dedicated his career to advancing patient care in both surgical and wound management disciplines. With

New CARDIOVERSE project combines AI, stem cells, and genetic variation to predict drug safety before human trials Developing new drugs is one of the riskiest and most expensive endeavors in science. Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 million contract from the Advanced

Toronto, Ontario–(Newsfile Corp. – December 8, 2025) – THS Maple Holdings Ltd. (TSXV: YAY) (the “Company” or “THS”), a leading producer and global distributor of maple syrup and maple-flavoured products, is pleased to announce its financial and operational results for the three-month period ended September 30, 2025. The results highlight the Company’s ongoing success in executing its

(NASDAQ:SNPS), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you